| Patient | Duke Kahanamoku |
|---|---|
| Date of birth | 1890-08-24 |
| Identifiers | MRN HR-ML050-SYN-TD; SSN (made up) 000-50-6847 |
| Document date | 1957-04-22 |
| Author | Kawika Lindgren-Morrison, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Vomiting and diarrhea for two days. [S]
Mr. Kahanamoku, a 66-year-old man with heart failure with reduced ejection fraction, called the heart failure nurse and was seen the same day. Two days ago he began vomiting and then had watery diarrhea, five or six times a day, without blood. Several people at his workplace have had the same illness this week. He has kept down only small sips of water since yesterday and has not taken his morning medicines today, but he took all of them yesterday, including spironolactone, which was started nine days ago. His home weight is 2.2 kg below his dry weight. He feels lightheaded on standing. He has no chest pain, palpitations, breathlessness, ankle swelling or fainting, and no fever above 38 degrees. [S]
| Element | Detail |
|---|---|
| Onset | Two days ago |
| Character | Vomiting, then watery diarrhea five or six times a day, without blood |
| Context | Similar illness among co-workers; heart failure medicines, spironolactone started nine days ago |
| Associated signs and symptoms | Lightheaded on standing; weight 2.2 kg below dry weight. Denies chest pain, breathlessness and fainting |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired and thirsty; low-grade temperature; weight down 2.2 kg |
| Gastrointestinal | Positive | Vomiting and watery diarrhea; mild cramping; no blood or black stools |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Negative | No breathlessness or orthopnea |
| Genitourinary | Positive | Passing little urine since yesterday |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1952-06-21 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1952-06-21 to 1957-03-16 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1957-03-16 | active | S |
| Metoprolol tartrate 25 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1952-06-21 to 1957-03-30 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1952-06-21 to 1957-03-30 | completed | S |
| Furosemide 40 mg oral tablet, one tablet every morning | One tablet every morning | Oral route | 1957-03-16 to 1957-04-27 | completed | S |
| Sacubitril 24 mg / valsartan 26 mg oral tablet, one tablet twice daily, first dose 36 hours after the last lisinopril | One tablet twice daily | Oral route | 1957-03-30 to 1957-09-28 | completed | S |
| Carvedilol 3.125 mg oral tablet, one tablet twice daily with food, starting the evening after the last metoprolol tartrate | One tablet twice daily with food | Oral route | 1957-03-30 to 1957-04-13 | completed | S |
| Carvedilol 6.25 mg oral tablet, one tablet twice daily with food | One tablet twice daily with food | Oral route | 1957-04-13 to 1957-04-27 | completed | S |
| Empagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating or drinking | One tablet daily, with sick-day rules | Oral route | 1957-03-30 | active | S |
| Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) daily | One-half tablet daily | Oral route | 1957-04-13 | active | S |
| Ferric carboxymaltose 750 mg (15 mL vial, 50 mg/mL) by intravenous infusion, two doses two weeks apart | Two infusions two weeks apart | Intravenous route | 1957-03-30 to 1957-04-13 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1957-04-22 | Body height | 185 | cm | S |
| 1957-04-22 | Body weight | 91.4 | kg | S |
| 1957-04-22 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 1957-04-22 | Systolic blood pressure | 102 | mm[Hg] | S |
| 1957-04-22 | Diastolic blood pressure | 62 | mm[Hg] | S |
| 1957-04-22 | Heart rate | 96 | /min | S |
| 1957-04-22 | Respiratory rate | 16 | /min | S |
| 1957-04-22 | Body temperature | 37.6 | Cel | S |
| 1957-04-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1957-04-22 | Sodium [Moles/volume] in Serum or Plasma | 133 | mmol/L | 135-145 mmol/L | Low | S |
| 1957-04-22 | Potassium [Moles/volume] in Serum or Plasma | 5.5 | mmol/L | 3.5-5.1 mmol/L | High | S |
| 1957-04-22 | Creatinine [Mass/volume] in Serum or Plasma | 1.52 | mg/dL | 0.74-1.35 mg/dL | High | S |
| 1957-04-22 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M | 50 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 1957-04-22 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 1957-04-22 | Magnesium [Mass/volume] in Serum or Plasma | 2.1 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
Vital signs recorded on 1957-04-22; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired but alert; seated blood pressure 102/62, pulse 96, temperature 37.6 |
| Orthostatic vital signs | Lying 108/66 mmHg, pulse 88; standing at three minutes 90/58 mmHg, pulse 108, with lightheadedness |
| Head and neck | Dry mucous membranes; jugular venous pressure not seen at 45 degrees |
| Cardiovascular | Regular rhythm; no gallop |
| Respiratory | Clear |
| Abdomen | Soft, mildly tender throughout, no guarding; active bowel sounds |
| Extremities | No edema |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determined | resolved | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology established heart failure with reduced ejection fraction. |
| Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1883 | active | confirmed | I25.2 | S — Synthetic modern diagnosis; the 1952 heart attack remains D in the history. |
| Heart failure with reduced ejection fraction from ischemic cardiomyopathy (ejection fraction 30% with a thinned, akinetic anterior wall and apex), NYHA class III at diagnosis | active | confirmed | I50.22 | S — Synthetic modern diagnosis made at the second visit; no claim that he had heart failure in his lifetime. |
| Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%) | active | confirmed | E61.1 | S — Synthetic finding at the heart failure workup. |
| Viral gastroenteritis for two days, with volume depletion, potassium 5.5 mmol/L and a rise in creatinine on sacubitril-valsartan, spironolactone, empagliflozin and furosemide; settled with sick-day rules | resolved | confirmed | A08.4 | S — Synthetic intercurrent problem at an unscheduled visit; it follows from his heart failure medicines and does not echo a documented illness. |
Guideline basis: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction (2024)
Follow-up: Heart failure nurse telephone call tomorrow. Review in five days with a metabolic panel. Go to the emergency department for fainting, vomiting that prevents any fluid intake, palpitations, weakness or chest pain. Next scheduled visit 1957-04-27: two-week review, five days after the sick visit: kidney function and potassium, medicine doses, lipids, and cardiac rehabilitation adapted to the ocean. [S]